We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.01B
AUM Growth
+$408M
Cap. Flow
+$69.4M
Cap. Flow %
1.73%
Top 10 Hldgs %
14.06%
Holding
1,291
New
51
Increased
572
Reduced
609
Closed
39

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$11.7M
2
JPM icon
JPMorgan Chase
JPM
+$11.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.8M
4
CVS icon
CVS Health
CVS
+$10.5M
5
SAP icon
SAP
SAP
+$9.82M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 15.32%
3 Healthcare 13.19%
4 Consumer Discretionary 10.16%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
351
LyondellBasell Industries
LYB
$19.2B
$2.36M 0.06%
28,425
-2,129
-7% -$174K
CRH icon
352
CRH
CRH
$66.8B
$2.34M 0.06%
58,797
-5,086
-8% -$190K
SYY icon
353
Sysco
SYY
$40.3B
$2.33M 0.06%
30,476
+5,878
+24% +$475K
PXD
354
DELISTED
Pioneer Natural Resource Co.
PXD
$2.31M 0.06%
10,107
+1,216
+14% +$296K
PUK icon
355
Prudential
PUK
$35.2B
$2.31M 0.06%
83,947
-10,180
-11% -$233K
KHC icon
356
Kraft Heinz
KHC
$30B
$2.28M 0.06%
55,997
+1,226
+2% +$46.6K
RACE icon
357
Ferrari
RACE
$72.5B
$2.28M 0.06%
10,626
-535
-5% -$110K
WAT icon
358
Waters Corp
WAT
$39.9B
$2.26M 0.06%
6,595
+651
+11% +$206K
FCX icon
359
Freeport-McMoran
FCX
$97.5B
$2.26M 0.06%
59,374
-59,716
-50% -$2.09M
WST icon
360
West Pharmaceutical
WST
$24.9B
$2.25M 0.06%
9,584
+681
+8% +$161K
WMB icon
361
Williams Companies
WMB
$86.1B
$2.25M 0.06%
68,315
+469
+0.7% +$15.3K
CAJ
362
DELISTED
Canon, Inc.
CAJ
$2.25M 0.06%
103,629
+1,986
+2% +$44.3K
LYG icon
363
Lloyds Banking Group
LYG
$91.3B
$2.24M 0.06%
1,016,618
-52,832
-5% -$109K
BWA icon
364
BorgWarner
BWA
$13.9B
$2.22M 0.06%
62,709
-2,451
-4% -$83.4K
TROW icon
365
T. Rowe Price
TROW
$24.3B
$2.22M 0.06%
20,322
+1,299
+7% +$147K
AME icon
366
Ametek
AME
$58.2B
$2.2M 0.05%
15,747
-2,923
-16% -$387K
GPC icon
367
Genuine Parts
GPC
$18.7B
$2.19M 0.05%
12,650
+970
+8% +$169K
JLL icon
368
Jones Lang LaSalle
JLL
$16.7B
$2.18M 0.05%
13,685
-435
-3% -$69.4K
MKC icon
369
McCormick & Company Non-Voting
MKC
$14.2B
$2.17M 0.05%
26,202
+446
+2% +$36K
HLN icon
370
Haleon
HLN
$44.2B
$2.17M 0.05%
270,709
+1,041
+0.4% +$7.08K
MTG icon
371
MGIC Investment
MTG
$6.25B
$2.15M 0.05%
165,730
+52,600
+46% +$692K
NTAP icon
372
NetApp
NTAP
$37.2B
$2.14M 0.05%
35,674
-5,914
-14% -$392K
TT icon
373
Trane Technologies
TT
$106B
$2.14M 0.05%
12,744
-86
-0.7% -$14.2K
CMS icon
374
CMS Energy
CMS
$22.3B
$2.14M 0.05%
33,765
-684
-2% -$40.4K
FNV icon
375
Franco-Nevada
FNV
$46B
$2.14M 0.05%
15,660
-1,678
-10% -$222K

Similar funds

Crossmark Global Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, Crossmark Global Holdings held 1,291 positions worth $4.01B, up 11% from $3.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Crossmark Global Holdings's Q4 2022 filing shows 51 new, 572 increased, 609 reduced and 39 closed positions. Its largest new stake was Berry Global Group, Inc.: 28,856 shares worth $1.6M. The largest sale was Intel, an estimated $11.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Crossmark Global Holdings's largest Q4 2022 buy was Berry Global Group, Inc.: 28,856 shares worth $1.6M.
  • Crossmark Global Holdings added most to Accenture in Q4 2022, an estimated $11.5M increase.
  • Crossmark Global Holdings's biggest Q4 2022 reduction was Intel, cutting an estimated $11.7M.
  • Crossmark Global Holdings fully exited CEMIG Preferred Shares in Q4 2022, selling an estimated $7.14M.
  • Crossmark Global Holdings's ten largest holdings make up 14% of its $4.01B portfolio in Q4 2022.
  • Crossmark Global Holdings opened 51 new positions and closed 39 in Q4 2022.
  • Crossmark Global Holdings's portfolio value rose 11% quarter-over-quarter to $4.01B.

Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.